Dietary resistant starch and chronic inflammatory bowel diseases

International Journal of Colorectal Disease

Volumn 14, Issue 4-5, 1999, Pages 201-211

  Jacobasch, Gisela ^a   Schmiedl, Detlef ^a   Kruschewski, Martin ^b   Schmehl, Katrin ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Absorption of short chain fatty acids; Apoptosis; Butyrate functions; Inflammatory bowel disease; Intestinal microflora; Matrix proteins; Proliferation; Resistant starch; TNBS rat model

Indexed keywords

ACETIC ACID; BUTYRIC ACID; DNA; ENEMA; FATTY ACID; LAMININ; PROPIONIC ACID; STARCH; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BACTERIAL GROWTH; BASEMENT MEMBRANE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHRONIC INFLAMMATION; COLON MUCOSA; CONTROLLED STUDY; DNA CONTENT; DNA SYNTHESIS INHIBITION; ENERGY METABOLISM; ENTERITIS; FERMENTATION; INTESTINE ABSORPTION; INTESTINE CRYPT; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; ULCERATIVE COLITIS;

EID: 0033451870     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840050212     Document Type: Review

References (49)

1. Ueda K (1986) Immunity provided by colonized enteric bacteria. Bifido Microflora 5:67-72
2. Cummings JH, Englyst HN (1987) Fermentation in the human large intestine and the available substrate. Am J Clin Nutr 45: 1243-1255
3. Englyst, HN, Kingman SM, Cummings JH (1992) Classification and measurement of nutritionally important starch fractions. Eur J Clin Nutr 46 [Suppl 2]:33-50
4. Cummings JH, Roberfroid MB, and members of the Paris Carbohydrate Group, Anderson H, Barth C, Ferro-Luzzie A, Ghoos Y, Gibney M, et al (1997) A new look at dietary carbohydrate: chemistry, physiology, and health. Eur J Clin Nutr 51:417-423
5. Kleesen B, Stoof G, Proll J, Schmiedl D, Noack J, Blaut M (1997) Feeding RS affects fecal and cecal microflora and short-chain fatty acids in rats. J Anim Sci 75:2453-2462
6. Velazquez OC, Seto RW, Bain A, Fisher J, Rombeau JL (1997) Deoxycholate inhibits in vivo butyrate-mediated BrdU labeling of the colonic crypt. J Surg Res 69:344-348
7. Velazquez OC, Seto RW, Choi J, Zhou D, Breen F, Fisher JD, Rombeau JL (1997) Butyrate inhibits deoxycholate-induced increase in colonic mucosal DNA and protein synthesis in vivo. Dis Colon Rectum 40:1368-1375
8. Velazquez OC, Lederer HM, Rombeau JL (1996) Butyrate and the colonocyte, implications for neoplasia. Dig Dis Sci 41: 727-739
9. Jacobasch G, Schmiedl D, Schmehl K (1997) Darmkrebsprävention durch resistente Stärke? Ernährungs Umschau 44:318-326, 369-373
10. Siavoshian S, Blottiere HM, Cherbut C, Galmiche J-P (1997) Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase expression in HT-29 colonic epithelial cells. Biochem Biophys Res Commun 232:169-172
11. Terranova VP, Rao CN, Kalebic T, Margulies IM, Liotta LA (1983) Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci USA 80:444-448
12. Wewer UM, Liotta LA, Jaye M, Ricca GA, Drohan WN, Claysmith AP, Rao CN, et al (1986) Altered levels of laminin receptor in RNA in various human carcinoma cells that have different abilities to bind laminin. Proc Natl Acad Sci USA 83: 7137-7141
13. Schmehl K, Florian S, Jacobasch G (1998) Changes in extracellular matrix composition in ulcerative colitis in man. FALK-Symposium 110:97
14. Schmehl K, Florian S, Jacobasch G, Salomon A, Körber J (1999) Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa. Int J Colorectal Dis (in press)
15. Chapman MAS, Grahn MF, Boyle MA, Hutton M, Rogers J, Williams NS (1994) Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 35:73-76
16. Stein J, Schröder O, Milovic V, Caspary W (1995) Mercaptopropionate inhibits butyrate uptake in isolated apical membrane vesicles of the rat distal colon. Gastroenterology 108: 673-679
17. Pitcher MCL, Cummings JH (1996) Hydrogen sulfide: a bacteria toxin in ulcerative colitis? Gut 39:1-4
18. D'Argenio G, Consenz, V, Cave MD, Iovino P, Valle ND, Lombardi G, Mazzacca G (1996) Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology 110:1727-1734
19. Butzner JD, Parmar R, Bell CJ, Dalal V (1996) Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 38:568-573
20. Cummings JH (1997) Short-chain fatty acid enemas in the treatment of distal ulcerative colitis. J Gastroenterol Hepatol 9: 149-153
21. Breuer RI, Soergal KH, Lashner BA, Christ ML, Hanauer SB, Vanagunas A, et al (1997) Short-chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo-controlled trial. Gut 40:485-491
22. Scheppach W, Sommer H, Kirchner T, Papanelli GM, Bartram P, Christi S, Richter F, Dusel G, Kasper H (1992) Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gut 38:886-893
23. Siems W, Grune T, Werner A, Gerber G, Buntrock P, Schneider W (1991) Influence of oxypurinol on colitis induced in rat colon by trinitrobenzene sulfonic acid treatment. Adv Exp Med Biol 309A:365-368
24. Younes M, Mohr A, Schoenberg MH, Schuldberg FW (1987) Inhibition of lipid peroxidation by superoxide dismutase following regional intestinal ischemia and reperfusion. Res Exp Med 187:9-17
25. Adjei AA, Morioka T, Ameho CK, Yamauchi K, Kulkarni AD, Al Mausouri HM, Kawajiri A, Yamamoto S (1996) Nucleoside-nucleotide-free diet protects rat colonic mucosa damage induced by trinitrobenzene sulfonic acid. Gut 39:428-433
26. Cruz T, Galvez J, Ocete MA, Crespo ME, Sanchez de Medina LH, Zarzuela A (1998) Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Sci 62: 687-695
27. Rohweder J, Foitzik T, Runkel N, Fromm M, Schulzke JD, Buhr HJ (1997) In vitro characterization of the intestinal barrier function in two experimental colitis models in the rat. Langenbecks Arch Chir Suppl Kongressbd 114:439-443
28. Den-Hond E, Hiele M, Evenepoel P, Peeters M, Ghoos Y, Rutgeerts P (1998) In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 115: 584-590
29. Foitzik T, Kruschewski M, Kroesen A, Buhr HJ (1999) Does microcirculation play a role in the pathogenesis of inflammatory bowel diseases? Int J Colorectal Dis 14:29-34
30. Stein J, Ries J, Barrett KE (1998) Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells. Am J Physiol 274:G203-209
31. Rietschel ET, Brade H (1992) Bacterial endotoxins. Sci Am 267: 54-61
32. Sartor RB (1997) Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther 11 [Suppl 3]:17-23
33. Garcia-Lafuente A, Antolin M, Guarner F, Vilaseca J, Malagelada JR (1996) Bacterial peptides enhance inflammatory activity in a rat model of colitis. Digestion 57:368-373
34. Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, Maxwell RJ, Rowlands BJ (1995) Significance of systemic endotoxinaemia in inflammatory bowel disease. Gut 36:897-901
35. Garcia-Lafuente A, Antolin M, Guarner F, Crespo E, Salas A, Forcada P, Laguarda M, Galvalda J, Baena JA, Vilaseca J, Malagelada JR (1997) Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol 272:G10-15
36. Wu S, Lim K-C, Huang J, Said RF, Sears CL (1998) Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci USA 95:14979-14984
37. Mullin JM, Snock KV (1990) Effect of tumor necrosis factor on epithelial tight junction and transepithelial permeability. Cancer Res 50:2172-2176
38. Madara JL, Stafford J (1989) Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83:724-727
39. Blomberg L, Henriksson A, Conway PL (1993) Inhibition of adhesion of Escherichia coli K88 to piglet ileal mucus by Lactobacillus spp. App Environ Microbiol 59:34-39
40. Roedinger WEW (1990) New directions in the aetiology of ulcerative colitis. Aust N Z J Surg 60:167-169
41. Tateishi H, Mitsuyama K, Toyonaga A, Tomoyose M, Tanikawa K (1997) Role of cytokines in experimental colitis: relation to intestinal permeability. Digestion 58:271-281
42. Hoffmann P, Zeeh JM, Lakshmanan J, Wu VS, Procaccino F, Reinshagen M, McRoberts JA, Eysselein VE (1997) Increased expression of transforming growth factor α precursors in acute experimental colitis in rats. Gut 41:195-202
43. Baert FJ, Rutgeerts PR (1999) Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications. Int J Colorectal Dis 14:47-51
44. Degnan BA, Macfarlane S, Macfarlane GT (1997) Utilization of starch and synthesis of a combined amylase/α-glucosidase by the human colonic anaerobe Bacteroides ovatus. J Appl Microbiol 83:359-366
45. May T, Mackie RJ, Fahey GC Jr, Cremin JC, Garleb KA (1994) Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scand J Gastroenterol 19:916-922
46. Gibson GR, Wang X (1994) Inhibitory effects of bifidobacteria on other colonic bacteria. J Appl Bacteriol 77:412-420
47. Zhang X.B, Ohta Y (1991) Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens. J Dairy Sci 74:1477-1481
48. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS (1997) Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18:833-841
49. Alander M, Satokari R, Korpela R, Saxeling M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A (1999) Persistence of colonization of human colonic mucosa by a probiotic strain. Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 65:351-354